The FDA has cleared PTC Therapeutics’ gene therapy for AADC deficiency, an ultra-rare disease that impacts the ...
AstraZeneca’s growth was driven by its portfolio of products in the oncology, biopharmaceuticals and rare disease segments ...
to use its artificial intelligence to identify novel rare disease indications for a discontinued drug asset. Under the terms of the agreement, Sanofi will provide data related to the unnamed drug ...
There are only 150 documented cases of this exceptionally rare and life-threatening disorder globally, with a survival rate beyond one year. The prevalence of this disease is approximately 1 in a ...
The brother of former Channel Nine reporter Hayley Webb has died from a rare brain disease. Lachlan Webb, who is the younger ...
Shares of the drugmaker were up about 5% in aftermarket trade. The therapy, sold under the brand name Kebilidi, is a one-time ...
AN ancient disease has been making a comeback and it could be caused by an acid reflux drug, a new study has warned. Health ...
Karl Fitzpatrick has described his frightening ordeal after being diagnosed with potentially life-threatening Guillain–Barré ...
Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and ...
Intercept’s US president Vivek Devaraj said the pharma company still believes in the evidence supporting the liver disease ...
A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...
Profit after tax came in ₹38.4 crore in Q2 of FY25, a recovery from a net loss of ₹11.8 crore in the first quarter of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback